91 related articles for article (PubMed ID: 18252681)
1. Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model.
Braithwaite RS; Roberts MS; Chang CC; Goetz MB; Gibert CL; Rodriguez-Barradas MC; Shechter S; Schaefer A; Nucifora K; Koppenhaver R; Justice AC
Ann Intern Med; 2008 Feb; 148(3):178-85. PubMed ID: 18252681
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of earlier initiation of antiretroviral therapy for uninsured HIV-infected adults.
Schackman BR; Goldie SJ; Weinstein MC; Losina E; Zhang H; Freedberg KA
Am J Public Health; 2001 Sep; 91(9):1456-63. PubMed ID: 11527782
[TBL] [Abstract][Full Text] [Related]
3. Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study.
May M; Gompels M; Delpech V; Porter K; Post F; Johnson M; Dunn D; Palfreeman A; Gilson R; Gazzard B; Hill T; Walsh J; Fisher M; Orkin C; Ainsworth J; Bansi L; Phillips A; Leen C; Nelson M; Anderson J; Sabin C
BMJ; 2011 Oct; 343():d6016. PubMed ID: 21990260
[TBL] [Abstract][Full Text] [Related]
4. Do benefits of earlier antiretroviral treatment initiation outweigh harms for individuals at risk for poor adherence?
Braithwaite RS; Roberts MS; Goetz MB; Gibert CL; Rodriguez-Barradas MC; Nucifora K; Justice AC
Clin Infect Dis; 2009 Mar; 48(6):822-6. PubMed ID: 19210173
[TBL] [Abstract][Full Text] [Related]
5. Early HIV treatment in the United States prevented nearly 13,500 infections per year during 1996-2009.
Goldman DP; Juday T; Seekins D; Linthicum MT; Romley JA
Health Aff (Millwood); 2014 Mar; 33(3):362-9. PubMed ID: 24590932
[TBL] [Abstract][Full Text] [Related]
6. When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data.
Cain LE; Robins JM; Lanoy E; Logan R; Costagliola D; Hernán MA
Int J Biostat; 2010; 6(2):Article 18. PubMed ID: 21972433
[TBL] [Abstract][Full Text] [Related]
7. Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives?
Braithwaite RS; Nucifora KA; Yiannoutsos CT; Musick B; Kimaiyo S; Diero L; Bacon MC; Wools-Kaloustian K
J Int AIDS Soc; 2011 Jul; 14():38. PubMed ID: 21801434
[TBL] [Abstract][Full Text] [Related]
8. Impact of Decarceration Plus Alcohol, Substance Use, and Mental Health Screening on Life Expectancies of Black Sexual Minority Men and Black Transgender Women Living With HIV in the United States: A Simulation Study Based on HPTN 061.
Feelemyer J; Bershteyn A; Scheidell JD; Brewer R; Dyer TV; Cleland CM; Hucks-Ortiz C; Justice A; Mayer K; Grawert A; Kaufman JS; Braithwaite S; Khan MR
J Acquir Immune Defic Syndr; 2024 Mar; 95(3):283-290. PubMed ID: 38032748
[TBL] [Abstract][Full Text] [Related]
9. Association of Retinal Vascular Caliber and Age-Related Macular Degeneration in Patients With the Acquired Immunodeficiency Syndrome.
Jabs DA; Van Natta ML; Pak JW; Danis RP; Hunt PW
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):904-908. PubMed ID: 29435590
[TBL] [Abstract][Full Text] [Related]
10. Is more research always needed? Estimating optimal sample sizes for trials of retention in care interventions for HIV-positive East Africans.
Uyei J; Li L; Braithwaite RS
BMJ Glob Health; 2017; 2(2):e000195. PubMed ID: 29081993
[TBL] [Abstract][Full Text] [Related]
11. Insurance status and mortality among patients with AIDS.
Jabs AW; Jabs DA; Van Natta ML; Palella FJ; Meinert CL;
HIV Med; 2018 Jan; 19(1):7-17. PubMed ID: 28696029
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Intermediate-stage Age-related Macular Degeneration in Patients With Acquired Immunodeficiency Syndrome.
Jabs DA; Van Natta ML; Pak JW; Danis RP; Hunt PW
Am J Ophthalmol; 2017 Jul; 179():151-158. PubMed ID: 28499708
[TBL] [Abstract][Full Text] [Related]
13. Using the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol.
Gwadz MV; Collins LM; Cleland CM; Leonard NR; Wilton L; Gandhi M; Scott Braithwaite R; Perlman DC; Kutnick A; Ritchie AS
BMC Public Health; 2017 May; 17(1):383. PubMed ID: 28472928
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of mobile phone text message interventions to improve adherence to HIV therapy in Kenya.
Patel AR; Kessler J; Braithwaite RS; Nucifora KA; Thirumurthy H; Zhou Q; Lester RT; Marra CA
Medicine (Baltimore); 2017 Feb; 96(7):e6078. PubMed ID: 28207516
[TBL] [Abstract][Full Text] [Related]
15. HIV Treatment in Resource-Limited Environments: Treatment Coverage and Insights.
Khademi A; Saure D; Schaefer A; Nucifora K; Braithwaite RS; Roberts MS
Value Health; 2015 Dec; 18(8):1113-9. PubMed ID: 26686798
[TBL] [Abstract][Full Text] [Related]
16. Impact and Cost-Effectiveness of Hypothetical Strategies to Enhance Retention in Care within HIV Treatment Programs in East Africa.
Kessler J; Nucifora K; Li L; Uhler L; Braithwaite S
Value Health; 2015 Dec; 18(8):946-55. PubMed ID: 26686778
[TBL] [Abstract][Full Text] [Related]
17. Implementing tobacco use treatment guidelines in community health centers in Vietnam.
Shelley D; VanDevanter N; Cleland CC; Nguyen L; Nguyen N
Implement Sci; 2015 Oct; 10():142. PubMed ID: 26453554
[TBL] [Abstract][Full Text] [Related]
18. Measuring the Potential Impact of Combination HIV Prevention in Sub-Saharan Africa.
Khademi A; Anand S; Potts D
Medicine (Baltimore); 2015 Sep; 94(37):e1453. PubMed ID: 26376383
[TBL] [Abstract][Full Text] [Related]
19. Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy: Results from a United States Cohort.
Jabs DA; Ahuja A; Van Natta ML; Lyon AT; Yeh S; Danis R;
Ophthalmology; 2015 Jul; 122(7):1452-63. PubMed ID: 25892019
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of intermediate-stage age-related macular degeneration in patients with acquired immunodeficiency syndrome.
Jabs DA; Van Natta ML; Sezgin E; Pak JW; Danis R;
Am J Ophthalmol; 2015 Jun; 159(6):1115-1122.e1. PubMed ID: 25769246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
